|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ando N, Iizuka T, Ide H, Ishida K, Shinoda
M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, et al
Japan Clinical Oncology Group, : Surgery plus chemotherapy compared
with surgery alone for localized squamous cell carcinoma of the
thoracic esophagus: A Japan Clinical Oncology Group
Study--JCOG9204. J Clin Oncol. 21:4592–4596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ando N, Kato H, Igaki H, Shinoda M, Ozawa
S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Allum WH, Stenning SP, Bancewicz J, Clark
PI and Langley RE: Long-term results of a randomized trial of
surgery with or without preoperative chemotherapy in esophageal
cancer. J Clin Oncol. 27:5062–5067. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Hagen P, Hulshof MC, van Lanschot JJ,
Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al CROSS Group, :
Preoperative chemoradiotherapy for esophageal or junctional cancer.
N Engl J Med. 366:2074–2084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hershko A and Ciechanover A: The ubiquitin
system. Annu Rev Biochem. 67:425–479. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohta T, Michel JJ, Schottelius AJ and
Xiong Y: ROC1, a homolog of APC11, represents a family of cullin
partners with an associated ubiquitin ligase activity. Mol Cell.
3:535–541. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kamura T, Conrad MN, Yan Q, Conaway RC and
Conaway JW: The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase
activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev.
13:2928–2933. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan P, Fuchs SY, Chen A, Wu K, Gomez C,
Ronai Z and Pan ZQ: Recruitment of a ROC1-CUL1 ubiquitin ligase by
Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol
Cell. 3:527–533. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakayama KI and Nakayama K: Ubiquitin
ligases: Cell-cycle control and cancer. Nat Rev Cancer. 6:369–381.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Petroski MD and Deshaies RJ: Function and
regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol.
6:9–20. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Frescas D and Pagano M: Deregulated
proteolysis by the F-box proteins SKP2 and beta-TrCP: Tipping the
scales of cancer. Nat Rev Cancer. 8:438–449. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohta T, Michel JJ and Xiong Y: Association
with cullin partners protects ROC proteins from
proteasome-dependent degradation. Oncogene. 18:6758–6766. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Swaroop M, Gosink M and Sun Y:
SAG/ROC2/Rbx2/Hrt2, a component of SCF E3 ubiquitin ligase: Genomic
structure, a splicing variant, and two family pseudogenes. DNA Cell
Biol. 20:425–434. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang J, Li S, Shang Z, Lin S, Gao P,
Zhang Y, Hou S, Mo S, Cao W, Dong Z, et al: Targeting the
overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in
esophageal cancer cells. Oncotarget. 8:29125–29137. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Migita K, Takayama T, Matsumoto S,
Wakatsuki K, Tanaka T, Ito M, Nishiwada S and Nakajima Y:
Prognostic impact of RING box protein-1 (RBX1) expression in
gastric cancer. Gastric Cancer. 17:601–609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia L, Soengas MS and Sun Y: ROC1/RBX1 E3
ubiquitin ligase silencing suppresses tumor cell growth via
sequential induction of G2-M arrest, apoptosis, and senescence.
Cancer Res. 69:4974–4982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei D, Morgan MA and Sun Y:
Radiosensitization of cancer cells by inactivation of cullin-RING
E3 ubiquitin ligases. Transl Oncol. 5:305–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nawrocki ST, Kelly KR, Smith PG, Espitia
CM, Possemato A, Beausoleil SA, Milhollen M, Blakemore S, Thomas M,
Berger A, et al: Disrupting protein NEDDylation with MLN4924 is a
novel strategy to target cisplatin resistance in ovarian cancer.
Clin Cancer Res. 19:3577–3590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nawrocki ST, Kelly KR, Smith PG, Keaton M,
Carraway H, Sekeres MA, Maciejewski JP and Carew JS: The
NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide
metabolism and augments the efficacy of cytarabine. Clin Cancer
Res. 21:439–447. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sobin LH and Compton CC: TNM seventh
edition: what's new, what's changed: Communication from the
International Union Against Cancer and the American Joint Committee
on Cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Japan Esophageal Society, . Japanese
Classification of Esophageal Cancer, 11th Edition: Part I.
Esophagus. 14:1–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakade H, Migita K, Matsumoto S, Wakatsuki
K, Kunishige T, Miyao S and Sho M: Overexpression of Cullin4A
correlates with a poor prognosis and tumor progression in
esophageal squamous cell carcinoma. Int J Clin Oncol. 25:446–455.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ito M, Migita K, Matsumoto S, Wakatsuki K,
Tanaka T, Kunishige T, Nakade H, Nakatani M and Nakajima Y:
Overexpression of E3 ubiquitin ligase tripartite motif 32
correlates with a poor prognosis in patients with gastric cancer.
Oncol Lett. 13:3131–3138. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Masuda TA, Inoue H, Sonoda H, Mine S,
Yoshikawa Y, Nakayama K, Nakayama K and Mori M: Clinical and
biological significance of S-phase kinase-associated protein 2
(Skp2) gene expression in gastric carcinoma: Modulation of
malignant phenotype by Skp2 overexpression, possibly via p27
proteolysis. Cancer Res. 62:3819–3825. 2002.PubMed/NCBI
|
|
27
|
Bai J, Zhou Y, Chen G, Zeng J, Ding J, Tan
Y, Zhou J and Li G: Overexpression of Cullin1 is associated with
poor prognosis of patients with gastric cancer. Hum Pathol.
42:375–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schindl M, Gnant M, Schoppmann SF, Horvat
R and Birner P: Overexpression of the human homologue for
Caenorhabditis elegans cul-4 gene is associated with poor outcome
in node-negative breast cancer. Anticancer Res. 27:949–952.
2007.PubMed/NCBI
|
|
29
|
Wang W, Qiu J, Liu Z, Zeng Y, Fan J, Liu Y
and Guo Y: Overexpression of RING box protein-1 (RBX1) associated
with poor prognosis of non-muscle-invasive bladder transitional
cell carcinoma. J Surg Oncol. 107:758–761. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang D, Li L, Liu H, Wu L, Luo Z, Li H,
Zheng S, Gao H, Chu Y, Sun Y, et al: Induction of autophagy and
senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the
growth of liver cancer cells. Cell Death Differ. 20:235–247. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jia L, Bickel JS, Wu J, Morgan MA, Li H,
Yang J, Yu X, Chan RC and Sun Y: RBX1 (RING box protein 1) E3
ubiquitin ligase is required for genomic integrity by modulating
DNA replication licensing proteins. J Biol Chem. 286:3379–3386.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schlabach MR, Luo J, Solimini NL, Hu G, Xu
Q, Li MZ, Zhao Z, Smogorzewska A, Sowa ME, Ang XL, et al: Cancer
proliferation gene discovery through functional genomics. Science.
319:620–624. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harper JW, Elledge SJ, Keyomarsi K,
Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley
L and Swindell E: Inhibition of cyclin-dependent kinases by p21.
Mol Biol Cell. 6:387–400. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang X, Pan Y, Qiu Z, Du Z, Zhang Y, Fa P,
Gorityala S, Ma S, Li S, Chen C, et al: RNF126 as a biomarker of a
poor prognosis in invasive breast cancer and CHEK1 inhibitor
efficacy in breast cancer cells. Clin Cancer Res. 24:1629–1643.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiao S, Liu W, Wu M, Peng C, Tang H and
Xie X: Nrdp1 expression to predict clinical outcome and efficacy of
adjuvant anthracyclines-based chemotherapy in breast cancer: A
retrospective study. Cancer Biomark. 15:115–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tian YF, Chen TJ, Lin CY, Chen LT, Lin LC,
Hsing CH, Lee SW, Sheu MJ, Lee HH, Shiue YL, et al: SKP2
overexpression is associated with a poor prognosis of rectal cancer
treated with chemoradiotherapy and represents a therapeutic target
with high potential. Tumor Biology. 34:1107–1117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gass P, Lux MP, Rauh C, Hein A, Bani MR,
Fiessler C, Hartmann A, Häberle L, Pretscher J, Erber R, et al:
Prediction of pathological complete response and prognosis in
patients with neoadjuvant treatment for triple-negative breast
cancer. BMC Cancer. 18:10512018. View Article : Google Scholar : PubMed/NCBI
|
